Experimental Therapies: New treatments for hepatitis B including pre-clinical development that have not yet been studied in humans, and various drugs that are in phase I, II and III development.



        459. Complementary and Alternative Medicine Use in Children with Chronic Viral Hepatitis (Updated Nov 1)

        821. Surface Antigen Seroconversion after Allogenic Hematopoietic Stem Cell Transplantation in Patient with Chronic Hepatitis B Virus Infection

        823. Efficacy of Hepatitis B Vaccine Against Antiviral Drug-resistant Hepatitis B Virus Mutants in the Chimpanzee Model

        824. New Insights into HBV Pathogenesis from Kinetic Analysis of HBeAg Titre Decay During Potent Antiviral Therapy.

        826. CD4+LAP+ Regulatory T Cells Mediate the Enhancement of the Anti-HBV Immune Response: A novel method for an adjuvant-dependent augmentation of anti-viral immunity

        875. Treatment of Chronic Viral Hepatitis in Woodchucks by Prolonged Intrahepatic Expression of Interleukin-12

        877. Drug-resistant and Wild-type Strains of HBV Are Inhibited Equally by Simvastatin

        879. Efficacy of RNAi Constructs for Inhibiting Hepatitis B Virus Replication Has Implications for Antiviral Cell and Gene Therapy

        949. Serine Palmitoyltransferase Inhibitor Suppresses Hepatitis B Virus Replication